cyclophosphamide,durvalumab,nab-paclitaxel,epirubicin
astrazeneca
['geparnuevo', 'thanks']
grateful &amp; honored to have presented an oral presentation at #asco23, thanks to the and for the opportunity to work with samples from the #geparnuevo trial. many thanks to the program commitee for the opportunity to share our findings. 
Senior Research Assistent 
#UniversitätsklinikumErlangen #FAU @UniFAU

* Gynecology 
* Obstetrics
* Cancer
* Smart Health